Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative chemoradiotherapy for esophageal and gastro-esophageal junction adenocarcinoma
2009-011174-15Phase 2Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and fluorouracil in esophageal adenocarcinoma (EAC) and gastroesophageal junction adenocarcinoma, sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Pathological complete response rate. Started Mar 2009; status: terminated.
02
Drugs
cisplatinfluorouracil
03
Conditions
esophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on 2009-011174-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011174-15.